Free tool
Oncology stocks
We cover 6 companies grouped under the Oncology theme. The median market value in the group is $4.32B. Across the group, the median move over the past trading day is +2.96%. Price change over the past year runs from +24.4% to +177.0% across the middle 80 percent of the group, with a median of +80.0%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
6 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| 6MK.DE | Merck & Co., Inc. | $380.73B | Mega cap | +83.96% |
| MRK | Merck & Co., Inc. | $371.70B | Mega cap | +88.17% |
| 0I3Q.L | Corcept Therapeutics Incorporated | $4.54B | Mid cap | +75.99% |
| IDYA | IDEAYA Biosciences, Inc. | $4.10B | Mid cap | +71.91% |
| ZLAB | Zai Lab Limited | $2.94B | Mid cap | −23.10% |
| XNCR | Xencor, Inc. Common Stock | $2.18B | Mid cap | +265.79% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.